FR EN

Back


27/11/2014
Idinvest makes 7.6x return with biotech exit
Paris-based private equity firm Idinvest is set to make a 7.6 return multiple on its $840 million sale of NASDAQ-listed biotechnology company Prosensa, according to a statement.




X

X

X

Eurazeo

One Group, One brand

On April 28, 2021, Idinvest Partners, a wholly-owned subsidiary of Eurazeo since 2020, changed its name to reflect its integral position in the Group.
All activities in the Private Equity, Private Debt and Real Assets businesses now share the single Eurazeo brand.

Find all the information on the Group, its businesses and its commitments on the eurazeo.com website.

www.eurazeo.com